Chief Medical Officer

South San Francisco, CA
Jul 02, 2021
Biotech Bay
Required Education
Bachelors Degree
Position Type
Full time

About Us:

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration.

Vaxart has demonstrated that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immuno-oncology indication.

Our mission is the promotion of global health through the development of effective vaccines that can be administered by tablet rather than by injection, providing for the simple and efficient distribution and administration of safe vaccines in any setting.

We are looking for a Chief Medical Officer to join our growing South San Francisco team!

* Please note that we cannot sponsor Visas at this time.


The Chief Medical Officer will report directly to the Chief Executive Officer. The primary role of the CMO will be to provide leadership and direction for Vaxart’s pipeline of clinical development programs for oral vaccines. The CMO will be responsible for the strategy, direction, and execution of the company’s clinical development plans. The CMO will be a key member of the senior management team as a member of the company’s Executive Committee which determines and oversees research and vaccine development at Vaxart and sets the overall strategic direction of the company. This is a unique opportunity to be a major contributor to the success of a well-positioned, well-financed growth-stage vaccines company.


  • Direct the development of clinical strategies and plans to develop vaccines and therapeutics.
  • Orchestrate and manage clinical aspects of regulatory strategies and interactions with Health Authorities
  • Oversee the analysis and interpretation of clinical trial data and the reporting of clinical trial results
  • Lead interactions with academic thought leaders, investigators, cooperative groups, and other clinical stakeholders
  • Provide clinical support and work with other members of the management team to develop and communicate the overall corporate strategy
  • Represent the Company and its programs to external audiences, including the investment, medical and regulatory communities, as well as pharmaceutical or biotechnology industry collaborators/partners
  • In addition to leading and supervising the Clinical Research Department, the CMO will have direct line responsibility for the Clinical Operations, Patient Advocacy, Medical Affairs, and Biometrics Departments


  • MD with Board Certification in infectious diseases, virology, immunology or Pediatrics with infectious diseases training preferred.
  • 15 years minimum experience in clinical practice treating patients plus pharmaceutical and/or biotechnology industry experience as a sponsor working on investigational new drugs.
  • Multiple years of management experience leading a clinical group including clinical/medical affairs and clinical operations.
  • A proven success record in Phase I-IV clinical research studies and trial design as well as the successful submission of IND’s and marketing approval-directed filings (BLA’s, NDA’s, and MAA’s).

Knowledge, Skills, and Abilities:

  • Knowledge of relevant FDA regulations and guidelines as well as those of the EU and other health authorities; experience in interactions with FDA personnel is essential; experience in interactions with other health authorities a plus.
  • Experience with, or strong knowledge of vaccine and drug development.
  • Experience or knowledge of infectious diseases/virology/immunology drug development a plus.
  • Experience in translational medicine, clinical pharmacology, and early-stage development is desirable.
  • Excellent knowledge of the competitive environment for drugs in the vaccine development marketplace and research and development pipelines.
  • Must have a thorough knowledge of clinical research concepts, practices, and GCP and ICH Guidelines.
  • The successful candidate will read, write and speak fluent English, possess excellent communication skills, and will be capable of articulating the Company’s clinical and regulatory strategies and progress to a wide audience including the CEO, the Board of Directors, Company employees, and the investor community.
  • Must have excellent leadership and interpersonal skills; should have proven skills as an effective team player who can engender credibility and confidence within and outside the company; must have outstanding executive presence.
  • Must be science- and data-driven.
  • For the best fit, the candidate must have the ability and strong desire to “make things happen”.
  • Must have a results-oriented work ethic and a positive, can-do attitude. Effective leadership, people management, communication skills and a team builder management style are essential; must be willing and able to be “hands on”.
  • Must have the highest personal values and ethical standards.

Vaxart offers team members a competitive compensation and benefits package, including a bonus program, stock options, 401(k) with employer matching, tuition assistance, and work life balance.

Vaxart is an Equal Opportunity Employer and values diversity. We are committed to the principles of equal employment opportunity and affirmative action for all applicants and employees. Equal opportunity and consideration are afforded to all qualified applicants and employees in personnel actions, which include: recruiting and hiring, selection for training, promotion, rates of pay or other compensation, transfer, discipline, demotion, layoff or termination. Vaxart does not unlawfully discriminate on the basis of race, color, religion, sexual orientation, marital status, pregnancy, gender identity, gender expression, family medical history or genetic information, citizenship, national origin or ancestry, sex, age, physical or mental disability, medical condition, veteran status, military status, or any other basis protected by federal, state or local law, ordinance or regulation.